Richard F Pollock Selected Research

Weight Loss (Weight Reduction)

10/2020	Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis.
5/2019	Correction to: A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA.
1/2019	A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA.
6/2018	Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard F Pollock Research Topics

Disease

16	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2010
15	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2024 - 01/2017
11	Hypoglycemia (Reactive Hypoglycemia) 01/2024 - 07/2017
5	Hypersensitivity (Allergy) 01/2024 - 01/2019
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024 - 12/2018
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2023 - 01/2018
5	Body Weight (Weight, Body) 10/2020 - 01/2011
4	Allergic Rhinitis 01/2024 - 01/2019
4	Weight Gain 10/2020 - 01/2011
4	Weight Loss (Weight Reduction) 10/2020 - 06/2018
2	Hypophosphatemia 01/2024 - 11/2023
2	Iron Deficiencies 01/2023 - 07/2020
2	Conjunctivitis 01/2023 - 11/2022
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 06/2020
2	Diabetes Complications 10/2019 - 06/2018
2	Myocardial Infarction 01/2019 - 07/2017
2	Stroke (Strokes) 01/2019 - 07/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2024
1	Anemia 01/2024
1	Anaphylaxis (Anaphylactic Shock) 06/2023
1	Neoplasms (Cancer) 01/2023
1	Non-Muscle Invasive Bladder Neoplasms 01/2023
1	Osteomalacia 01/2023
1	Chronic Renal Insufficiency 04/2022
1	Diabetes Mellitus 04/2022
1	Vomiting 10/2020
1	Diarrhea 10/2020
1	Nausea 10/2020
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Colorectal Neoplasms (Colorectal Cancer) 10/2020
1	Liver Neoplasms (Liver Cancer) 06/2020
1	Asthma (Bronchial Asthma) 01/2019
1	Primary Immunodeficiency Diseases 01/2018
1	Ketosis 07/2017
1	Macular Edema 07/2017
1	Heart Failure 07/2017
1	Cytomegalovirus Infections (Inclusion Disease) 10/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Turner Syndrome (Turner's Syndrome) 03/2015
1	Osteoporosis 11/2011

Drug/Important Bio-Agent (IBA)

14	IronIBA 01/2024 - 01/2017
9	ferric carboxymaltoseIBA 01/2024 - 12/2018
9	Insulin (Novolin)FDA Link 12/2023 - 06/2010
8	Insulin Glargine (Lantus)FDA Link 10/2019 - 01/2011
6	ferric derisomaltoseIBA 01/2024 - 01/2020
5	iron isomaltoside 1000IBA 07/2020 - 01/2017
5	insulin degludecIBA 10/2019 - 01/2018
4	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2023
4	Blood Glucose (Blood Sugar)IBA 01/2024 - 01/2010
4	TabletsIBA 01/2024 - 01/2019
4	semaglutideIBA 10/2020 - 06/2018
4	dulaglutideIBA 05/2019 - 06/2018
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2024 - 06/2018
3	Saccharated Ferric Oxide (Venofer)FDA Link 11/2023 - 01/2020
3	SirtuinsIBA 01/2023 - 06/2020
2	AllergensIBA 01/2023 - 11/2022
2	Exenatide (Byetta)FDA Link 05/2019 - 01/2019
2	Insulin Detemir (Levemir)FDA Link 01/2018 - 01/2011
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018 - 01/2011
2	Insulin Lispro (Humalog)FDA Link 07/2016 - 12/2012
2	InsulinsIBA 12/2012 - 01/2012
2	Biphasic InsulinsIBA 12/2012 - 06/2010
1	Lomustine (CCNU)FDA Link 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Phosphates (Orthophosphate)IBA 11/2023
1	Immunoglobulin E (IgE)IBA 01/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2020
1	trifluridine tipiracil drug combinationIBA 10/2020
1	regorafenibIBA 10/2020
1	Tyrosine Kinase InhibitorsIBA 06/2020
1	Yttrium-90IBA 06/2020
1	lenvatinibIBA 06/2020
1	Sorafenib (BAY 43-9006)FDA Link 06/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	GrazaxIBA 01/2019
1	Protamines (Protamine Sulfate)FDA Link 01/2018
1	Isophane Insulin (NPH Insulin)FDA Link 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	rGLP-1 proteinIBA 07/2016
1	Sitagliptin Phosphate (Januvia)FDA Link 07/2016
1	Glucagon-Like Peptide-1 ReceptorIBA 07/2016
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016
1	Growth Hormone (Somatotropin)IBA 03/2015
1	Diphosphonates (Bisphosphonates)IBA 11/2011

Therapy/Procedure

5	Therapeutics 01/2024 - 01/2019
4	Immunotherapy 01/2024 - 06/2020
4	Injections 01/2024 - 10/2020
4	Glycemic Control 10/2023 - 02/2018
2	Radiotherapy 01/2023 - 06/2020
2	Drug Therapy (Chemotherapy) 10/2020 - 01/2019
2	Liver Transplantation 06/2020 - 10/2016
1	Oral Administration 11/2023
1	Intravenous Administration 11/2023
1	Brachytherapy 01/2023
1	Cystectomy 01/2023
1	Microspheres (Microsphere) 06/2020
1	Radiofrequency Ablation 06/2020
1	Surgical Amputation (Amputations) 07/2017
1	Transplantation 01/2016